TesaIpa is a research peptide blend combining tesamorelin and ipamorelin for laboratory investigation of growth hormone–related signaling pathways. Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), while ipamorelin is a growth hormone secretagogue associated with ghrelin receptor (GHSR) signaling. The combination provides researchers with a defined research material for studying two distinct signaling inputs involved in the regulation of growth hormone release. TesaIpa is supplied by Helix Bio strictly for research and laboratory use and is not intended for human or veterinary administration.
HPLC certified
Independent analysis
Highest standard
Full traceability
What Is TesaIpa?
TesaIpa refers to a peptide combination containing tesamorelin and ipamorelin. The two compounds are associated with different components of growth hormone signaling:
Tesamorelin has been investigated for its ability to influence endogenous growth hormone pulsatility, while ipamorelin has been studied as a selective growth hormone secretagogue. Research involving the two compounds can therefore examine complementary mechanisms within the growth hormone axis.
Importantly, the presence of tesamorelin in this research blend should not be confused with FDA-approved prescription tesamorelin products. FDA records identify tesamorelin as the active substance in Egrifta products, but a research-use-only material from Helix Bio is a separate product and is not an FDA-approved drug.
TesaIpa contains two research peptides:
Tesamorelin: A GHRH analog used in research involving GHRH receptor activity, pituitary signaling, growth hormone secretion, and related endocrine pathways.
Ipamorelin: A growth hormone secretagogue studied in connection with the ghrelin receptor, also known as the growth hormone secretagogue receptor (GHSR).
The exact blend ratio and total quantity should always be confirmed from the specific product label and batch documentation supplied with the material.
TesaIpa is intended for laboratory research where investigators need to examine the interaction between different growth hormone secretagogue pathways.
Research may focus on:
Published research has shown that tesamorelin can influence endogenous GH pulsatility and IGF-I levels in controlled experimental settings, making the compound relevant to research on the regulation of the growth hormone axis.
Important Product Distinction
TesaIpa is a research-use-only peptide blend. It should not be represented as a finished pharmaceutical, dietary supplement, or approved therapeutic combination.
Helix Bio states that its products are intended exclusively for research and laboratory purposes and are not intended for ingestion, injection, diagnosis, treatment, cure, or prevention of disease.
Researchers studying peptide signaling often need materials with clearly defined identities and supporting analytical documentation. TesaIpa provides a way to investigate two different signaling inputs associated with growth hormone regulation within a single research material.
Helix Bio's catalog describes a quality-control process involving HPLC purity analysis, mass spectrometry identity confirmation, and batch-specific Certificates of Analysis. These records can help researchers evaluate the identity and stated purity of the material before incorporating it into a laboratory workflow.
The combination is particularly relevant when the research question involves comparing or examining the relationship between GHRH-mediated and GHSR-mediated signaling.
TesaIpa is intended for qualified users conducting legitimate scientific or laboratory research, including:
It is not intended for consumers seeking personal health, cosmetic, performance, weight-management, or therapeutic applications.
| Specification | Details |
|---|---|
| Product Name | TesaIpa |
| Product Type | Peptide blend |
| Components | Tesamorelin + Ipamorelin |
| Research Category | Growth Hormone Secretagogue / Peptide Blend |
| Primary Research Area | Growth hormone axis and peptide signaling |
| Physical Form | Lyophilized research material, where specified |
| Purity | Verify current batch-specific COA |
| Identity Testing | Mass spectrometry, according to Helix Bio's stated testing program |
| Purity Testing | HPLC, according to Helix Bio's stated testing program |
| Documentation | Batch-specific Certificate of Analysis |
| Intended Use | Laboratory and scientific research only |
| Human Use | Not intended for human use |
| Veterinary Use | Not intended for veterinary use |
| Manufacturer / Supplier | Helix Bio |
| Country of Origin | Not specified; verify current product documentation |
Note: Product-specific quantity, blend ratio, purity result, and other analytical specifications should be taken from the current lot's Certificate of Analysis rather than assumed from general catalog information.
TesaIpa can be relevant to laboratory research involving the growth hormone axis and peptide signaling.
GHRH Receptor Research
Tesamorelin is a synthetic GHRH analog. Research involving this component can examine GHRH receptor activation and downstream effects associated with pituitary growth hormone signaling.
GHSR Research
Ipamorelin is studied in relation to the growth hormone secretagogue receptor, also called GHSR or the ghrelin receptor. This makes it relevant to laboratory investigation of receptor-mediated signaling.
Growth Hormone Signaling Studies
The combination can be used as a research material for examining different regulatory inputs associated with growth hormone release and related endocrine signaling.
Peptide-Receptor Interaction Research
TesaIpa can be relevant to studies investigating how structurally different peptide ligands interact with receptors and influence downstream signaling pathways.
Comparative Research
Researchers may use separate peptide materials or combination materials when comparing signaling pathways, experimental responses, or receptor-specific mechanisms. The appropriate experimental design depends on the research question and validated laboratory protocol.
Published human research on tesamorelin has examined changes in endogenous growth hormone pulsatility and IGF-I in controlled study settings. Those findings provide scientific context for the compound but should not be interpreted as evidence for the safety or efficacy of this research-use-only TesaIpa product.
Quality documentation is particularly important when working with peptide research materials because identity and purity can directly affect experimental interpretation.
Helix Bio states that its research peptide catalog uses:
HPLC Purity Analysis
High-performance liquid chromatography (HPLC) is used to evaluate peptide purity. HPLC can help researchers identify the relative proportion of the target compound and potential impurities within a sample.
Mass Spectrometry
Mass spectrometry is used for molecular identity and mass confirmation. This provides an additional analytical check alongside chromatographic purity testing.
Batch-Specific COA
Helix Bio states that every product is supported by a batch-specific Certificate of Analysis. Researchers should review the applicable COA for the exact TesaIpa lot being evaluated, including reported purity, identity, testing methods, and other available analytical information.
No Unsupported Certification Claims
A Certificate of Analysis should not be interpreted as FDA approval, clinical certification, or evidence that a research material is suitable for administration to people or animals.
Follow the storage conditions supplied with the specific product and lot documentation.
General laboratory handling considerations include:
Specific stability after opening, reconstitution, or other preparation should not be assumed unless supported by product-specific stability data.
Helix Bio's website describes its research materials as being packaged for laboratory research and states that its fulfillment process includes cold-chain handling and tracked shipping. Product-specific packaging and shipping conditions should be confirmed against the current order information and applicable shipping policy.
Research materials should remain appropriately labeled throughout transportation, receipt, storage, and laboratory handling.
Shipping does not change the product's research-use-only status.
TesaIpa is offered strictly as a research-use-only laboratory material.
It is not a prescription drug, dietary supplement, food product, or finished pharmaceutical. It is not intended for human or veterinary consumption, ingestion, injection, self-administration, diagnosis, treatment, cure, mitigation, or prevention of any disease or medical condition.
The product has not been evaluated by the U.S. Food and Drug Administration for use as a human or veterinary product in this research-use-only form. The existence of FDA-approved prescription products containing tesamorelin does not mean that a research-use-only TesaIpa blend is FDA-approved or equivalent to those products.
Researchers are responsible for complying with applicable federal, state, local, institutional, laboratory, and regulatory requirements. All experimental work should be performed by appropriately qualified personnel under established laboratory protocols.
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
What bacteriostatic water contains, how it differs from sterile water and saline, where the 28-day opened-vial figure comes from, and what a COA can show.
Do you need a prescription for peptides? It depends on the category. See which peptides need one, which do not, and the dated 2026 FDA rules that apply.
The complete 2026 list of FDA-approved peptides: 47 drugs by category and approval year, which popular peptides are not approved, and pipeline to watch.
